Home › Funds › Defilade Capital Management, L.P. › SOLV
Defilade Capital Management, L.P. position in SOLV
SOLVENTUM CORP · Health Care
Defilade Capital Management, L.P. reported holding 316,454 shares of SOLV (SOLVENTUM CORP) in its Q2 2026 13F filing — a position valued at US$24.4M, representing 3.27% of its reported portfolio and ranking #13 among its reported holdings. Defilade Capital Management, L.P. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Defilade Capital Management, L.P.'s SOLV position evolved
Defilade Capital Management, L.P. first disclosed a stake in SOLV in Q2 2026 at 316,454 shares (US$24.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 316.45K | $24.41M | New |
About SOLV and 13F data
SOLV (SOLVENTUM CORP) is a Health Care company. 45 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.25B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$486.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SOLV
- Independent Franchise Partners LLP 16.17M sh · $1.25B · Q2 2026
- TRIAN FUND MANAGEMENT, L.P. 8.24M sh · $635.47M · Q2 2026
- DAVIS SELECTED ADVISERS 6.31M sh · $486.69M · Q2 2026
- Diamond Hill Capital Management, LLC (Investment Advisor) 1.95M sh · $150.07M · Q2 2026
- Madison Avenue Partners, LP 1.74M sh · $134.34M · Q2 2026
- EQUITY INVESTMENT CORP 882.02K sh · $68.05M · Q2 2026
- Ruffer LLP 776.47K sh · $59.84M · Q2 2026
- ANCHOR CAPITAL ADVISORS LLC 582.76K sh · $44.96M · Q2 2026
More on Defilade Capital Management, L.P.
FAQ
How long has Defilade Capital Management, L.P. held SOLV?
Defilade Capital Management, L.P. has disclosed SOLV holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Defilade Capital Management, L.P.'s current position in SOLV?
As of Q2 2026, Defilade Capital Management, L.P. holds 316.45K shares of SOLV (SOLVENTUM CORP), valued at $24.41M, representing 3.27% of its reported portfolio and ranking #13.
Has Defilade Capital Management, L.P. been buying or selling SOLV?
In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. newly opened its position in SOLV.
Which other funds hold SOLV?
Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.